申请人:Shionogi & Co., Ltd.
公开号:US04529721A1
公开(公告)日:1985-07-16
A compound of the formula: ##STR1## wherein u represents hydrogen, carboxamido, N-hydroxycarboxamido, carboxy, azido, an aryl, an acylamino, a protected carboxy or an N-alkoxycarboxamido, or, together with v, can represent --S-- or --CH.sub.2 S--; v represents hydrogen, halogen, cyano or an alkylthio, or, together with u, can represent --S-- or --CH.sub.2 S--, or, together with w, can represent --(CH.sub.2).sub.3 CO--; w represents hydrogen, carboamoyl, cyano, carboxy, an N-alkylcarbamoyl, an alkyl, an aryl, a protected carboxy or a heterocycle, or, together with v, can represents --(CH.sub.2).sub.3 CO--; x represents halogen, trifluoromethyl, an alkylthio or an arylthio; y represents hydrogen, a light metal or a carboxylic acid protecting group; and z represents an acyloxy or a heterocycle-thio, each of the above radicals represented by the symbols u, v, w, x, y and z being optionally substituted by halogen or a carbon-, nitrogen-, oxygen- or sulfur-containing functional group, a process for preparing the compound, a pharmaceutical composition containing the compound, and a therapeutical use of the compound. A compound of the formula: ##STR2## wherein u, v, w and x are as defined above, useful as a starting compound for preparing the compound (I) is also provided.
该化合物的化学式为:##STR1## 其中u代表氢、羧酰胺、N-羟基羧酰胺、羧基、叠氮基、芳基、酰胺基、保护羧基或N-烷氧基羧酰胺,或与v一起表示--S--或--CH.sub.2 S--;v代表氢、卤素、氰基或烷基硫基,或与u一起表示--S--或--CH.sub.2 S--,或与w一起表示--(CH.sub.2).sub.3 CO--;w代表氢、羧酰基、氰基、羧基、N-烷基氨基甲酰、烷基、芳基、保护羧基或杂环基,或与v一起表示--(CH.sub.2).sub.3 CO--;x代表卤素、三氟甲基、烷基硫基或芳基硫基;y代表氢、轻金属或羧酸保护基;z代表酰氧基或杂环硫,上述u、v、w、x、y和z代表的基团可以选择地被卤素或含碳、氮、氧或硫的功能基团取代,提供了制备该化合物的方法、含有该化合物的制药组合物以及该化合物的治疗用途。提供了化合物的化学式为:##STR2## 其中u、v、w和x如上所定义,可用作制备化合物(I)的起始化合物。